The aim of the presented study is to describe the Polish population of patients with EGFR-mutated advanced NSCLC receiving first-line EGFR-TKI therapy in the REFLECT study, focusing on treatment patterns and T790M testing practice. Here, EGFR is linked to non-small cell lung carcinoma.